Related Experiment Video
Updated: Aug 13, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Early Antiretroviral Therapy Reduces Severity but Does Not Eliminate Neurodevelopmental Compromise in Children With
Sarah Benki-Nugent1, Nancy Tamasha2, Alice Mueni2
1Department of Global Health, University of Washington, Seattle.
Insights
Starting antiretroviral therapy (ART) in infancy for children with HIV attenuates neurodevelopmental deficits but does not fully eliminate them. Early ART improves cognitive and motor outcomes compared to late ART, though some impairments persist compared to HIV-unexposed children.
Area of Science:
- Pediatric Infectious Diseases
- Neurodevelopmental Disorders
- HIV/AIDS Research
Background:
- Human Immunodeficiency Virus (HIV) infection in children can lead to neurodevelopmental impairments.
- Early initiation of antiretroviral therapy (ART) is crucial for managing HIV in infants.
- The precise extent of cognitive benefits from early ART in pediatric HIV is not fully understood.
Purpose of the Study:
- To evaluate the long-term neurodevelopmental outcomes in children with HIV who received early ART versus late ART.
- To compare the cognitive, behavioral, and motor outcomes of children with HIV (early and late ART) against HIV-unexposed uninfected children (CHUU).
Main Methods:
- Cognitive, behavioral, and motor assessments were conducted in three groups: children with HIV and early ART (<1 year), children with HIV and late ART (1.5-6 years), and CHUU.
- Domain z scores and odds of neurobehavioral impairment were compared using adjusted analyses.
- Participants were recruited from HIV care centers in Nairobi, Kenya.
Main Results:
- Children receiving late ART showed significantly poorer outcomes across multiple cognitive, learning, and motor domains compared to those receiving early ART.
- Children receiving early ART still exhibited lower cognitive and behavioral regulation scores compared to CHUU, indicating persistent neurodevelopmental compromise.
- Children receiving late ART had the most significant deficits across nearly all assessed domains compared to CHUU.
Conclusions:
- Initiating ART within the first year of life significantly mitigates but does not entirely prevent the neurodevelopmental consequences of HIV infection in children.
- While early ART improves outcomes, ongoing monitoring and support are necessary for children with HIV to address residual neurodevelopmental challenges.
Background:
Early antiretroviral therapy (ART) during infancy reduces cognitive impairment due to HIV, but the extent of benefit is unclear.
Setting:
Children were recruited from hospital and health centers providing HIV care and treatment in Nairobi, Kenya.
Methods:
Cognitive, behavioral, and motor outcomes were assessed in children with HIV and early ART (<1 year), children with HIV and late ART (1.5-6 years), and children HIV-unexposed uninfected (CHUU). Domain z scores and odds neurobehavioral impairment (≤15th percentile in CHUU) were compared in adjusted analyses.
Results:
Children with HIV initiated ART at median ages 0.4 (early ART) and 3.5 years (late ART). Children were assessed at median ages 6.9 (CHUU, N = 61), 6.9 (early ART, N = 54), and 13.5 (late ART; N = 27) years. Children with late ART vs. children with early ART had significantly lower z scores in 7 domains, specifically global cognition, short-term memory, visuospatial processing, learning, nonverbal test performance, executive function, and motor skills (adjusted mean differences, -0.42 to -0.62, P values ≤ 0.05), and had higher odds impairment in 7 domains (adjusted odds ratios [aORs], 2.87 to 16.22, P values ≤ 0.05). Children with early ART vs. CHUU had lower z scores in 5 domains (global cognition, short-term memory, delayed memory, processing speed, and behavioral regulation [adjusted mean differences, -0.32 to -0.88, P values < 0.05]) and higher impairment for 2 domains (short-term memory [aOR, 3.88] and behavioral regulation [aOR 3.46], P values < 0.05). Children with late ART vs. CHUU had lower z scores in 8 domains (adjusted mean differences, -0.57 to -1.05, P values ≤ 0.05), and higher impairment in 7 domains (aORs 1.98 to 2.32, P values ≤ 0.05).
Conclusion:
Early ART in the first year of life attenuates but does not eliminate the neurodevelopmental compromise of HIV.
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Retroviruses
Alzheimer's Disease: Treatment
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

